Join us in Philadelphia from Sept. 25-27th for our "Together We Will" Weekend: - Register today!

“Tumor volume and T2 hyperintensity changes from DeFi: a phase 3, randomized, controlled trial of nirogacestat in patients with desmoid tumors”